{"id":2691,"date":"2016-06-13T09:22:05","date_gmt":"2016-06-13T06:22:05","guid":{"rendered":"http:\/\/info.e-med.co.il\/buzztest\/?p=2691"},"modified":"2023-11-22T10:03:37","modified_gmt":"2023-11-22T08:03:37","slug":"efficacy-and-safety-of-a-medical-device-versus-placebo-in-the-early-treatment-of-patients-with-symptoms-of-urinary-tract-infection-a-randomized-controlled-trial","status":"publish","type":"post","link":"https:\/\/info.e-med.co.il\/utiproplus\/2016\/06\/13\/efficacy-and-safety-of-a-medical-device-versus-placebo-in-the-early-treatment-of-patients-with-symptoms-of-urinary-tract-infection-a-randomized-controlled-trial\/","title":{"rendered":"Efficacy and Safety of a Medical Device versus Placebo in the Early Treatment of Patients with Symptoms of Urinary Tract Infection: A Randomized Controlled Trial"},"content":{"rendered":"

Abstract<\/h2>\n
\n
Background<\/strong>: The objective of the study was to analyze the efficacy and safety of a medical device containing reticulated gelatin with hibiscus and propolis (RGHP) in the early treatment of patients with symptoms of urinary tract infection (UTI).<\/p>\n

Methods<\/strong>: A double-blind, placebo-controlled trial was carried out in 60 patients who were randomized (1:1) to RGHP or placebo twice daily for 5 days. Follow-up was 11 days.<\/p>\n

Results<\/strong>: The risk ratio of patients who needed antibiotic treatment was lower in the RGHP group (RR, 0.3; 95% CI, 0.09 to 0.98). RGHP provided greater symptom relief than placebo (mean adjusted change in the global symptom score from baseline: -5.27 vs. 0.40; p<0.001). Adverse events were reported by 6.67% and 3.33% of patients (RGHP and placebo, respectively, p=0.5).<\/p>\n

Conclusions<\/strong>: RGHP was more effective than placebo in improving UTI symptoms and reduced the need for rescue antibiotic treatment.<\/p>\n<\/section>\n<\/div>\n

\u05dc\u05d4\u05de\u05e9\u05da \u05e7\u05e8\u05d9\u05d0\u05d4<\/a><\/p>\n

Garcia-Larrosa A et al. Efficacy and safety of a medical device versus placebo in the early treatment of patients with symptoms of urinary tract infection: a randomized controlled trial. Clin Microbiol. 2016, 5:1. DOI: 10.4172\/2327-5073.1000233<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Abstract Background: The objective of the study was to analyze the efficacy and safety of a medical device containing reticulated gelatin with hibiscus and propolis (RGHP) in the early treatment of patients with symptoms of urinary tract infection (UTI). Methods: A double-blind, placebo-controlled trial was carried out in 60 patients who were randomized (1:1) to […]<\/p>\n","protected":false},"author":2,"featured_media":3663,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,6,3],"tags":[],"class_list":["post-2691","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-article-en","category-research","category-updates-news"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t